To accelerate translational cancer research so that precise, impactful and cost-effective treatments can benefit cancer patients, OICR has implemented a new Clinical Translation Pathway (CTP) to support preclinical, clinical, and convergent research. The CTP consists of four separate funding streams and is currently inviting applications for the Innovation to Implementation (I2I) funding opportunity which is focused on overcoming barriers to the mobilization, or uptake, of knowledge required to facilitate adoption of research into policy or healthcare. OICR is committed to providing research funding to help support a sustainable health system that enables fair and equitable access to cancer interventions. 

How to apply: Download the Request for Applications [PDF]

Examples of eligible studies include: 

• Studies that facilitate movement of research-generated knowledge to actual application of such knowledge in population health, screening, or clinical practice settings
• Studies that enable engagement of new users, including patients, along the translational continuum to advance the research into clinical settings
• Studies that adapt a research tool for use in cancer prevention, clinical settings or clinical trials
• Studies that conduct economic analysis or generate real-world evidence required to inform adoption of research into policy or routine healthcare
• Studies evaluating the comparative real-world clinical- and cost‐effectiveness of interventions
• Knowledge Translation activities that will advance the adoption of research into policy or routine healthcare

Eligibility

OICR invites applications from investigators at Ontario academic centres, hospital research institutes or other government research institutions.  There is no limit to the number of applications investigators are eligible to submit as PI or Co-PI. OICR is focused on developing and supporting the next generation of cancer researchers, and strongly encourages applicants to include early career investigators/clinicians as part of the project team. Further, teams should consider the inclusion of a physician and/or a biostatistician for relevant projects.  This Request for Applications does not require previous OICR funding support in order to be eligible. 

Funding available

Up to $100,000 per year, inclusive of overhead, for a maximum of two years. OICR funding is only tenable in Ontario. For-profit entities are not eligible to receive OICR funding.

Deadlines

RFA information session: Slide deck from September 20 information session
Letter of Intent (LOI) deadline: October 13, 2022 by 5 p.m. ET
LOI results communicated: Week of November 14, 2022 
Full application deadline: January 19, 2023 by 5 p.m. ET
Notification of results: March 2023
Funding to begin: April 1, 2023

Questions

Please refer to the FAQ page before contacting the OICR Scientific Secretariat office at ScientificSecretariat@oicr.on.ca.

How to apply: Download the Request for Applications [PDF]